JAK3/BTK-IN-4 是一种有效的JAK3/BTK抑制剂。BTK 和 JAK3 是自身免疫性疾病的两个重要靶点。同时抑制 BTK/JAK3 信号通路表现出协同效应。JAK3/BTK-IN-4 具有研究 JAK3 激酶和/或 BTK 相关疾病的潜力 (摘自专利 WO2021147953A1，化合物 003)。

JAK3/BTK-IN-4 is a potent inhibitor of JAK3 / BTK. BTK and JAK3 are two important targets for autoimmune diseases. Simultaneous inhibition of the BTK/JAK3 signalling pathway exhibits synergistic effects. JAK3/BTK-IN-4 has the potential for the research of JAK3 kinase and/or BTK-related diseases (extracted from patent WO2021147953A1, compound 003) [1]

2673196-38-6

C21H25ClN8O

440.93

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years